Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis
New England Journal of Medicine · 16.07.2026 · 395 (3) · 311-312
DOI: 10.1056/nejmc2602619 ↗Kurz gefasst
Leserbrief in der Zeitschrift New England Journal of Medicine, erschienen am 16.07.2026. Verfasst von Michele Marchini und 1 weiteren Autor:innen. Beteiligte Einrichtung: Azienda Sociosanitaria Ligure 5, La Spezia, Italy. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
To the Editor: In the PISCES trial (Protection against Incidences of Serious Cardiovascular Events Study), Lok et al. (Jan. 8 issue) 1 report a lower incidence of serious cardiovascular events among participants receiving maintenance hemodialysis and daily supplementation with fish oil (high-dose n−3 fatty acids) than among those receiving maintenance hemodialysis and daily supplementation with corn-oil placebo. The hazard ratio of 0.57 reflected a larger benefit than that seen in most previous trials of n−3 fatty acids and is potentially practice-changing. However, background intake of marine n−3 fatty acids differs markedly across geographic regions. The consumption of fish in Canada and . . .
Autor:innen und Institutionen
- Azienda Sociosanitaria Ligure 5, La Spezia, Italy.
Zitieren
APA
Marchini, M., & Trezzi, M. (2026). Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis. New England Journal of Medicine, 395(3), 311-312. https://doi.org/10.1056/nejmc2602619
Vancouver
Marchini M, Trezzi M. Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis. New England Journal of Medicine. 2026;395(3):311-312. doi:10.1056/nejmc2602619
BibTeX
@article{Marchini2026,
author = {Marchini, Michele and Trezzi, Matteo},
title = {Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis},
journal = {New England Journal of Medicine},
year = {2026},
volume = {395},
number = {3},
pages = {311--312},
doi = {10.1056/nejmc2602619}
}
EUVIMED